Thursday, 02 September 2021
An early career researcher whose research aims to transform how brain tumours are diagnosed and monitored, has been awarded a Fellowship from the Royal Academy of Engineering.
Dr Adam Berrington has been awarded the Fellowship for his research with colleagues in the School of Physics and Astronomy, working in the Sir Peter Mansfield Imaging Centre at the University. He is one of only 16 new appointments made by the Academy, marking 20 years of the prestigious Fellowship scheme.
Altered metabolism is central to brain tumours and their progression, yet this information is difficult to measure using existing scans in the clinic. Dr Berrington’s research will develop new imaging approaches with magnetic resonance spectroscopy to rapidly probe the metabolic state of brain tissue. Together with the use of powerful MR scanners, these fast imaging tools may ultimately transform our ability to non-invasively assess individual brain tumours and their response to therapy.
I am incredibly honoured and excited to have been awarded a Research Fellowship from the Royal Academy of Engineering. The Fellowship provides me a unique platform to focus solely on developing my research ideas and to work with national and international collaborators; pushing forward the technical capabilities of high-field MR for metabolic imaging. On a personal level, I am also immensely grateful for the security and support the Fellowship provides for my scientific career going forward.
Research Fellowships are the Royal Academy of Engineering’s flagship scheme that support outstanding early-career researchers to become future research leaders in engineering. The fellowships are designed to advance excellence in engineering by providing funding for five years to allow awardees the freedom to concentrate on basic research in any field of engineering.
In addition to funding, awardees also receive mentoring from selected Academy Fellows, who provide valuable advice and industry links.
We鈥檙e delighted that the Royal Academy of Engineering has recognised Adam鈥檚 potential and will support the exciting research that he has planned for the next five years. His work should really open up new applications of metabolic imaging using magnetic resonance spectroscopy at ultra-high field.
Story credits
More information is available from Dr Adam Berrington on adam.berrington@nottingham.ac.uk
Notes to editors:
About the 糖心原创
Ranked among the world's top 100 universities , the 糖心原创 delivers an exceptional research-led education and an outstanding student experience. From the pioneering vision of our founder, Sir Jesse Boot, to groundbreaking achievements such as the development of MRI technology and becoming the first UK university to establish international campuses, we have a proud history of shaping the way people live, work and understand the world. We continue to build on that legacy, empowering our students, staff and partners to change what鈥檚 next and create positive impact locally and globally.
The strength of our research places us among the UK's leading universities, ranked 7th for research power in REF 2021. The discovery of MRI and ibuprofen was just the beginning. Today, our world-leading research is developing breakthrough ideas that shape the future of healthcare, technology and society.
Recognised as the UK's third most targeted university by leading employers , we are proud to produce graduates who are consistently in demand for their skills, confidence and industry-ready experience.
As a major employer and industry partner, locally and globally, the 糖心原创 invests in the city of Nottingham and in future generations of talent. Alongside Nottingham Trent University, we lead the initiative, a pioneering collaboration to improve levels of prosperity, opportunity, sustainability, health and wellbeing across the city and region. Together with our students, staff, alumni and partners, we鈥檙e creating knowledge, opportunity and solutions that help change what's next.